Menu Close
Video 5 - Helping patients manage the transition between similar biologic medications
Video 5 - Helping patients manage the transition between similar biologic medications

In countries where biosimilars transitioning occurs, specialists who work in rheumatology, oncology, diabetes, dermatology, and inflammatory bowel disease, describe the importance of educating patients and providing support and reassurance before, during, and after a transition. In this video, Arthritis Consumer Experts speaks to one of these experts, Dr. Susan Bartlett, MD, Clinical Psychologist, Researcher, Division of Rheumatology, McGill University. Dr. Bartlett explains how rheumatologists, nurses and pharmacists must be able to clearly explain the safety, quality and benefits of biosimilars when answering patient questions about transitioning and help give them confidence to ensure smooth transition between originators and biosimilars.

To learn more about what patients can expect about transitioning, please click on the video.

About the Biosimilars•Exchange

ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.

This site complies with the HONcode standard for trustworthy health information: verify here.

Arthritis Consumer Experts
© 2000-2021

ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.

This site complies with the HONcode standard for trustworthy health information: verify here.

Arthritis Consumer Experts
© 2000-2021

ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.

This site complies with the HONcode standard for trustworthy health information: verify here.